Hepcinat contain oral nucleotide analog inhibitor of the hepatitis C virus (HCV) polymerase. Chawla Medicos have been setting benchmarks of success in the market as a prominent organization engaged in offering Hepcinat. These are antiviral drug, used in combination with other drugs for treatment of hepatitis C. Our expert agents source Hepcinat tablets from India the trusted and certified vendors of the market. We offer these Hepcinat Tablets at affordable prices to clients. Features:
Provide a higher cure rate
Low indication of side effects
Effective anti viral drug
Product Description Hepcinat Tablets (Sofosbuvir 400 mg)-Generic Sovaldi suppliers, distributors in Delhi, India. Brand Name: Hepcinat Tablets Generic Name: Sofosbuvir Strength: 400 mg Form: Tablets Trade Name: HEPCINAT 400mg Manufactured By NATCO PHARMA LIMITED Composition: Each film coated tablet contains: Sofosbuvir equivalent to Sofosbuvir 400 mg. Sofosbuvir 400mg tablets is an antiviral drug which is used in combination with other drugs for treatment of Hepatitis C Virus (HCV) infection. Compared to previous treatments, sofosbuvir based regimens provide a higher cure rate, fewer side effects, and a two- to four-fold reduced duration of therapy.
Mechanism of Action:- Sofosbuvir contains oral nucleotide analog inhibitor of the hepatitis C virus (HCV) polymerase. The drug is a direct-acting antiviral agent and interferes straight with the HCV lifecycle, restraining the viral replication. It can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator. The drug is available for oral use in the form of HEPCINAT 400mg tablets. Dosage and Administration: The recommended daily dose of Sofosbuvir is 400 mg tablet to be taken once daily with or without food. Sofosbuvir should be used in combination with Ribavirin or in combination with PEGylated Interferon and Ribavirin for the treatment of CHC (Chronic Hepatitis C) in adults. It is highly advisable to administer the drug under strict medical supervision and advice. Side Effects: Adverse events associated with the use of Sofosbuvir in combination with Ribavirin may include but are not limited to, the following
Fatigue
Headache
Adverse events associated with the use of Sofosbuvir in combination with Peginterferon Alfa and Ribavirin may include, but are not limited to, the following:
Fatigue
Headache
Nausea
Insomnia
Anaemia